GEO DataSets

(Submitter supplied) The goal of this study was to assess the changes in the neural transcriptome of Ptenm3m4 mice, in order to better understand their ASD-related phenotypes. For our initial cellular and behavioral characterization of this mouse line, see Tilot, et al., Human Molecular Genetics, 2014

Organism:

Mus musculus

Type:

Expression profiling by high throughput sequencing

Platform:

GPL13112

18 Samples

Download data: CSV, DIFF

(Submitter supplied) We investigated the relationship between chronic inflammation and fibrosis in a mouse model of chronic colitis. Six weekly Trinitrobenzenesulphonic acid (TNBS) enemas were given to establish colitis and temporal changes in gene expression was elucidated over the next six weeks. Keywords: disease state analysis

Organism:

Mus musculus

Type:

Expression profiling by array

Platform:

GPL81

7 Samples

Download data

(Submitter supplied) In this series the ocular primordium was microdissected from normal CD-1 (outbred) mouse embryos harvested days 8-10 post-coitus, corresponding to human development during the 3rd-4th weeks post-fertilization. The precise embryological age was ascertained by counting somite pairs to an accuracy of +/- 2 pairs per litter. Samples were pooled as follows: optic pit pooled from 48-50 embryos (6 litters) on 8 d.p.c. more...

Organism:

Mus musculus; Rattus norvegicus

Type:

Expression profiling by array

Platform:

GPL560

14 Samples

Download data

(Submitter supplied) This series compares the effects that two pharmacologically distinct ligands at the mitochondrial peripheral-type benzodiazepine receptor (Bzrp) has on gene expression in early mouse embryos cultured under different oxygen levels. Mouse embryos averaging 16-18 somite pairs were explanted on 9 d.p.c. and grown in culture under optimal oxygenation (21% oxygen, hyperbaric with respect to arterial blood = 80-100 mmHg). more...

Organism:

Mus musculus

Type:

Expression profiling by array

Platform:

GPL560

10 Samples

Download data

(Submitter supplied) In this time course pregnant CD-1 (outbred) dams were exposed to MeHg as monomethylmercuric chloride intraperitoneally on 9 d.p.c. The test dose of 5.0 mg/kg MeHg was selected as a dose with an estimated 20% increased risk for encephalopathy in term fetuses, with no evidence of maternal toxicosis. Exposed embryos were co-treated with PK11195, a nontoxic ligand of the mitochondrial peripheral-type benzodiazepine receptor (Bzrp) that effectively suppresses developmental toxicity induced with MeHg. more...

Organism:

Mus musculus

Type:

Expression profiling by array

Dataset:

GDS637

Platform:

GPL560

9 Samples

Download data

(Submitter supplied) In this time course pregnant CD-1 (outbred) dams were exposed to MeHg as monomethylmercuric chloride intraperitoneally on 9 d.p.c. The test dose of 5.0 mg/kg MeHg was selected as a dose with an estimated 20% increased risk for encephalopathy in term fetuses, with no evidence of maternal toxicosis. Sampling intervals ranged from 1.5h to 24.0h post-exposure. All measurements were on RNA from the embryonic forebrain (prosencephalon) using contemporous control embryos as a reference. more...

Organism:

Mus musculus

Type:

Expression profiling by array

Dataset:

GDS636

Platform:

GPL560

13 Samples

Download data

(Submitter supplied) In this dose series pregnant CD-1 (outbred) dams were exposed to methylmercury (MeHg) as monomethylmercuric chloride injected intraperitoneally on 9 d.p.c. Test doses were 10.0 mg/kg and below. This regimen induces symptoms of Fetal Minimata Disease (FMD) in term fetuses. Risks with respect to FMD for the various test doses were 10.0 mg/kg (40% risk), 5.0 mg/kg (20% risk), 2.5 mg/kg (NOAEL), and 1.25 mg/kg (subNOAEL). more...

Organism:

Mus musculus

Type:

Expression profiling by array

Dataset:

GDS635

Platform:

GPL560

8 Samples

Download data

(Submitter supplied) This series compares the effects that two pharmacologically distinct ligands at the mitochondrial peripheral-type benzodiazepine receptor (Bzrp). PK11195 (4.0 mg/kg, a presumed antagonist) has no observable adverse effects in pregnant mice on either 8 days post-coitus (d.p.c.) or 9 d.p.c. Furthermore, PK11195 is shown to rescue mouse fetuses from microphthalmia or microphthalmia-microcephaly induced with 2CdA or MeHg, respectively; effects of PK11195 on EtOH-induced craniofacial malformations are not yet unkown. more...

Organism:

Mus musculus

Type:

Expression profiling by array

Platform:

GPL560

22 Samples

Download data: GPR

(Submitter supplied) In this time course pregnant CD-1 (outbred) dams were exposed to the 2-chloro analogue of 2'-deoxyadenosine (a metabolic toxin) on 8 d.p.c. The test dose of 2.5 mg/kg 2CdA was modeled for a 5% increased risk of microphthalmia in term fetuses. Exposed embryos were co-treated with PK11195, a nontoxic ligand of the mitochondrial peripheral-type benzodiazepine receptor (Bzrp) that effectively blocks p53 protein induction and developmental toxicity induced with 2CdA. more...

Organism:

Mus musculus

Type:

Expression profiling by array

Dataset:

GDS632

Platform:

GPL560

8 Samples

Download data

(Submitter supplied) In this time course pregnant CD-1 (outbred) dams were exposed to the 2-chloro analogue of 2'-deoxyadenosine (a metabolic toxin) on 8 d.p.c. The test dose of 2.5 mg/kg 2CdA was modeled for a 5% increased risk of microphthalmia in term fetuses. Sampling intervals were anchored to the conditional biomarker (p53 protein induction) expressed in 2CdA-treated embryos between 3.0- and 4.5h post-exposure. Since p53 protein induction has been defined as a critical event in 2CdA-induced micropthalmia, these sampling intervals represent times before (3.0h), during (4.5h), and after (6.0h) this critical event. more...

Organism:

Mus musculus

Type:

Expression profiling by array

Dataset:

GDS631

Platform:

GPL560

8 Samples

Download data

(Submitter supplied) In this dose series pregnant CD-1 (outbred) dams were exposed to the 2-chloro analogue of 2'-deoxyadenosine (a metabolic toxin) on 8 d.p.c. Test doses were developed from a teratological series for 2CdA-induced microphthalmia using BMDS modeling software from the US EPA. Benchmark doses for microarray analysis were: 5.0 mg/kg (25% risk), 2.5 mg/kg (5% risk), 1.25 mg/kg (NOAEL), and 0.625 mg/kg (subNOAEL). more...

Organism:

Mus musculus

Type:

Expression profiling by array

Dataset:

GDS630

Platform:

GPL560

8 Samples

Download data

Temporal analysis of methylmercury (MeHg) exposure, and PK11195 intervention. Pregnant 9 days post coitum CD-1 dams injected with 5.0 mg/kg MeHg. Embryonic forebrain examined at 3, 4.5 and 6 hours. MeHg induces symptoms of fetal minamata disease (FMD).

Organism:

Mus musculus

Type:

Expression profiling by array, log ratio, 3 time sets

Platform:

GPL560

Series:

GSE1077

7 Samples

Download data

Temporal analysis of methylmercury (MeHg) exposure in embryos. Pregnant 9 days post coitum CD-1 dams injected with 5.0 mg/kg MeHg. Embryonic forebrain examined at 1.5 - 24 hours post-treatment. MeHg induces symptoms of fetal minamata disease (FMD).

Organism:

Mus musculus

Type:

Expression profiling by array, log ratio, 6 time sets

Platform:

GPL560

Series:

GSE1076

13 Samples

Download data

Dose response analysis of methylmercury (MeHg) exposure in embryos. Pregnant 9 days post coitum CD-1 dams injected with 10, 5, 2.5, or 1.25 mg/kg MeHg. Embryonic forebrain examined after 3 hours. MeHg induces symptoms of fetal minamata disease (FMD).

Organism:

Mus musculus

Type:

Expression profiling by array, log ratio, 4 dose sets

Platform:

GPL560

Series:

GSE1075

8 Samples

Download data

Temporal analysis of ocular teratogen 2-chloro-2'deoxyadenosine (2CdA) exposure in developing embryos, intervention with PK11195, and induction of microphthalmia (small eye syndrome). Embryonic headfold examined at 3, 4.5, and 6 hours.

Organism:

Mus musculus

Type:

Expression profiling by array, log ratio, 3 time sets

Platform:

GPL560

Series:

GSE1070

6 Samples

Download data

Temporal analysis of ocular teratogen 2-chloro-2'deoxyadenosine (2CdA) exposure and induction of microphthalmia (small eye syndrome). Pregnant 8 days post coitum CD-1 dams exposed to 2.5 mg/kg 2CdA, and embryonic headfold examined at 3, 4.5, and 6 hours.

Organism:

Mus musculus

Type:

Expression profiling by array, log ratio, 3 time sets

Platform:

GPL560

Series:

GSE1069

6 Samples

Download data

Dose response analysis of ocular teratogen 2-chloro-2'deoxyadenosine (2CdA) exposure and induction of microphthalmia (small eye syndrome). Pregnant 8 days post coitum CD-1 dams exposed to 5, 2.5, 1.25 or 0.625 mg/kg 2CdA, and embryos examined at 3 hours.

Organism:

Mus musculus

Type:

Expression profiling by array, log ratio, 4 dose sets

Platform:

GPL560

Series:

GSE1068

8 Samples

Download data